In this present study, the expression levels of p53 induced by Compound 5a were higher in the metastatic SW620 cells than in primary adenocarcinoma HT29, which could confirm the more potent anticancer activity of Compound 5a in SW620 cells than in HT29 cells. Here, TP53 is linked to adenocarcinoma.